'Big Leap' Towards Curing Blindness in Stem Cell Study
By BBC,
BBC News
| 07. 21. 2013
The prospect of reversing blindness has made a significant leap, according to scientists in the UK.
An animal study in the journal Nature Biotechnology showed the part of the eye which actually detects light can be repaired using stem cells.
The team at Moorfields Eye Hospital and University College London say human trials are now, for the first time, a realistic prospect.
Experts described it as a "significant breakthrough" and "huge leap" forward.
Photoreceptors are the cells in the retina which react to light and convert it into an electrical signal which can be sent to the brain.
However, these cells can die off in some causes of blindness such as Stargardt's disease and age-related macular degeneration.
There are already trials in people to use stem cells to replace the "support" cells in the eye which keep the photoreceptors alive.
Blind mice
Now the London-based team have shown it is possible to replace the light-sensing cells themselves, raising the prospect of reversing blindness.
They have used a new technique for building retinas in the laboratory. It was used to...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...